Page last updated: 2024-11-06

lysergic acid diethylamide and Hodgkin Disease

lysergic acid diethylamide has been researched along with Hodgkin Disease in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berliner, AD1
Distenfeld, A1

Other Studies

1 other study available for lysergic acid diethylamide and Hodgkin Disease

ArticleYear
Hodgkin's disease in a married couple.
    JAMA, 1972, Aug-14, Volume: 221, Issue:7

    Topics: Adult; Cannabis; Chromosome Aberrations; Chromosome Disorders; Female; Hodgkin Disease; Humans; Lyse

1972